moved for leave to introduce Bill C-239, an act to amend the Consumer Packaging and Labelling Act (recombinant hormones).
Mr. Speaker, this bill is directed toward the ethical and health components of new technology. Genetic engineering is evident with bovine growth hormone. This bill would make certain that those individuals who wish to have the choice to use or not use milk produced in this way would have the product labelled. The bill has larger implications in terms of genetic technology in general. It will also look at labelling of other foods that are genetically engineered.
(Motions deemed adopted, bill read the first time and printed)